NM_001018005.2:c.341A>G
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP3PP5_Moderate
The NM_001018005.2(TPM1):c.341A>G(p.Glu114Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E114Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001018005.2 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- dilated cardiomyopathy 1YInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001018005.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TPM1 | NM_001018005.2 | MANE Select | c.341A>G | p.Glu114Gly | missense | Exon 3 of 10 | NP_001018005.1 | ||
| TPM1 | NM_001365778.1 | c.467A>G | p.Glu156Gly | missense | Exon 4 of 10 | NP_001352707.1 | |||
| TPM1 | NM_001407322.1 | c.467A>G | p.Glu156Gly | missense | Exon 4 of 11 | NP_001394251.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TPM1 | ENST00000403994.9 | TSL:1 MANE Select | c.341A>G | p.Glu114Gly | missense | Exon 3 of 10 | ENSP00000385107.4 | ||
| TPM1 | ENST00000267996.11 | TSL:1 | c.341A>G | p.Glu114Gly | missense | Exon 3 of 9 | ENSP00000267996.7 | ||
| TPM1 | ENST00000288398.10 | TSL:1 | c.341A>G | p.Glu114Gly | missense | Exon 3 of 10 | ENSP00000288398.6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
The Glu114Gly variant (TPM1) has not been previously reported, but has been iden tified in 1 individual with DCM out of >2000 Caucasian probands tested by our la boratory. This low frequency supports a pathogenic role. In addition, glutamic a cid (Glu) is highly conserved across evolutionarily distant species, increasing the likelihood that a change would not be tolerated. Finally, this variant was p redicted to be pathogenic using a computational tool, which was validated by our laboratory using a set of cardiomyopathy variants with well-established clinica l significance. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). In summary, the Glu114Gly variant is likely to be pa thogenic, though segregation studies and functional analyses are required to est ablish this with certainty.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at